CD86 and rheumatoid arthritis: The in vitro treatment of peripheral blood mononuclear cells of patients with rheumatoid arthritis with HSP70 induces the production of IL-10, and Mycobacterium tuberculosis HSP70 (mtHS70) blocks the maturation of bone marrow precursors that fail to express MHC class II and CD86.